SCHEMBL622798

SCHEMBL622798

BrC1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599832 0.87
SCHEMBL5785673 0.79
SCHEMBL264306 0.79
SCHEMBL14476043 0.79
SCHEMBL265179 0.73
SCHEMBL29991186 0.72
SCHEMBL3212874 0.69
SCHEMBL60586 0.69
SCHEMBL248830 0.69
SCHEMBL23682710 0.67 TTR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 955 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486929-A Substituted alkyl germanium compound and modularized synthesis method thereof 西安交通大学 2024-02-02 CN claimed
CN-115011974-B Method for preparing trans-allylbenzene compound by electrocatalytic reaction 哈尔滨工业大学(深圳) 2023-08-04 CN claimed
CN-114645288-B Preparation method of trans-olefin compound 哈尔滨工业大学(深圳) 2023-08-01 CN claimed
CN-115011974-A Method for preparing trans-allyl benzene compound through electrocatalysis 哈尔滨工业大学(深圳) 2022-09-06 CN claimed
CN-114645288-A Preparation method of trans-olefin compound 哈尔滨工业大学(深圳) 2022-06-21 CN claimed
CN-112645971-B Method for directly preparing alkyl borate compound from alkyl halide 中国科学院兰州化学物理研究所 2021-12-24 CN claimed
US-3931236-A Oxidation and dehydrohalogenation of halotetrahydropyrans PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US claimed
EP-4746963-A1 MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2026-05-27 EP disclosed
WO-2026107227-A1 COMPOSITIONS COMPRISING USP1 INHIBITORS AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2026-05-21 WO disclosed
WO-2026107208-A1 COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS THE METHODIST HOSPITAL (US) 2026-05-21 WO disclosed
US-12630565-B2 DNA-dependent protein kinase inhibitor DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) 2026-05-19 US disclosed
US-12624053-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2026-05-12 US disclosed
EP-4736856-A2 BICYCLIC AMINES AS CDK2 INHIBITORS Incyte Corporation (US) 2026-05-06 EP disclosed
US-3989721-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-11-02 US disclosed
US-3989720-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-11-02 US disclosed
US-3988352-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-10-26 US disclosed
US-3979414-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-09-07 US disclosed
US-3965115-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-22 US disclosed
US-3963753-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-15 US disclosed
US-3963752-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-15 US disclosed